genXone S.A. (WSE:GX1)
Poland · Delayed Price · Currency is PLN 6.48
-0.02 (-0.31%)
Last updated: Apr 15, 2026, 12:50 PM CET
genXone Market Cap
genXone has a market cap or net worth of 21.42 million as of April 16, 2026. Its market cap has increased by 12.50% in one year.
Market Cap
21.42M
Enterprise Value
18.06M
Revenue
2.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.48
Market Cap Chart
Since September 4, 2020, genXone's market cap has decreased from 141.69M to 21.42M, a decrease of -84.89%. That is a compound annual growth rate of -28.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 21.42M | 62.41% |
| Dec 30, 2025 | 13.19M | -35.65% |
| Dec 30, 2024 | 20.49M | 15.53% |
| Dec 29, 2023 | 17.74M | -47.33% |
| Dec 30, 2022 | 33.67M | -51.33% |
| Dec 30, 2021 | 69.20M | 0.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.83B |
| NEUCA | 3.15B |
| Synektik Spólka Akcyjna | 2.57B |
| Celon Pharma | 1.14B |
| Airway Medix | 37.41M |
| Pure Biologics | 37.16M |
| Pharmena | 37.09M |
| Medicofarma Biotech | 33.17M |